Clinical Trials Browser

Phase EARLY_PHASE1 × Recruiting × Lung Neoplasms × Clear all

NCT05493566 2026-02-12

Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer

Phase EARLY_PHASE1 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05620342 2026-02-05

Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer

Phase EARLY_PHASE1 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT07236177 2026-02-05

B-GLUCANCER2

Phase EARLY_PHASE1 Recruiting

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT06645808 2025-12-29

VARTUTRACE

Phase EARLY_PHASE1 Recruiting

BreastCNSGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Chondrosarcoma, Colonic Neoplasms, Esophageal Neoplasms, Glioblastoma, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Osteosarcoma, Stomach Neoplasms

NCT05543954 2024-07-05

68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients

Phase EARLY_PHASE1 Recruiting

Lung Neoplasms

NCT06329908 2024-03-26

DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs

Phase EARLY_PHASE1 Recruiting

Lung Neoplasms